Molecular Mechanism of Enhanced Anticancer Effect of Nanoparticle Formulated LY2835219 via p16-CDK4/6-pRb Pathway in Colorectal Carcinoma Cell Line

Figure 6

Schematic representation of anticancer effect and mechanism of LY2835219-loaded nanoparticles on HT29 cell line.